General Oral Abstracts

A Survey of Canine Cancer Genomic Biomarkers Based on Structured Literature Review, Meta-Analysis, and Comparative Genomics Survey of Canine Cancer Genomic Biomarkers
Guannan Wang

Lymphotropic Nanoparticle Magnetic Resonance Imaging for Diagnosing Metastatic Lymph Nodes Lymphotropic Nanoparticle MRI
Lynn Griffin

Predicting Dynamic Clinical Outcomes of the (L-)CHOP Chemotherapy for Canine Lymphoma Patients Using an Artificial Intelligence Model (L-)CHOP Chemotherapy for Canine Lymphoma
Sungwon Lim

Zoledronic Acid and Coarsely Fractionated External Beam Radiotherapy: Effective Limb-Sparing Therapy for Canine Osteosarcoma Zoledronic Acid & Radiotherapy for Osteosarcoma
Brian Flesner

Single Cell T Cell Receptor Repertoire Profiling for Dogs Single Cell T Cell Receptor Repertoire Profiling
Jeffrey Bryan

Preclinical Development of Bispecific Car T Cells for Canine B Cell Malignancies Bispecific CAR T Cells for B Cell Malignancies
Matthew Atherton

Characterization of a Fully Canine Anti-Canine CTLA4 Antibody for Checkpoint Inhibition in Canine Cancer Anti-Canine CTLA4 Antibody for Checkpoint Inhibition
Nicola Mason

Two Prospective Trials Demonstrate Lower Risk for Malignancy in Canine Hemoperitoneum Secondary to Ruptured Splenic Tumors Risk for Malignancy in Hemoperitoneum
Samuel Stewart

The Shine on Program for Early Detection and Prevention of Canine Hemangiosarcoma Shine On Program for Hemangiosarcoma
Taylor DePauw

Sequencing the Epigenome of Splenic Tumors May Uncover New Insight into the Biology and Therapy of Canine Splenic Hemangiosarcoma Sequencing Epigenome of Splenic Tumors
Jacob Cawley

Propranolol Reduces Hemangiosarcoma Cell Viability by Disrupting Lipid Homeostasis and Inducing ER Stress Propranolol Reduces Hemangiosarcoma Cell Viability
Erin Dickerson